Matches in Wikidata for { <http://www.wikidata.org/entity/Q91313998> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q91313998 description "article scientifique publié en 2018" @default.
- Q91313998 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91313998 description "scientific article published on 21 September 2018" @default.
- Q91313998 description "wetenschappelijk artikel" @default.
- Q91313998 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91313998 name "Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US" @default.
- Q91313998 name "Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US" @default.
- Q91313998 type Item @default.
- Q91313998 label "Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US" @default.
- Q91313998 label "Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US" @default.
- Q91313998 prefLabel "Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US" @default.
- Q91313998 prefLabel "Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US" @default.
- Q91313998 P1433 Q91313998-C9B4DE5F-F606-4A8F-A97B-7FA69D3EA717 @default.
- Q91313998 P1476 Q91313998-9C95654F-8CF9-48E3-985B-74FC9947DB40 @default.
- Q91313998 P2093 Q91313998-1F1B5D27-EDEA-422A-BD6C-881973561A8A @default.
- Q91313998 P2093 Q91313998-3AD2EDD5-59DD-47F0-8C12-C75C88A6AD93 @default.
- Q91313998 P2093 Q91313998-9008D8E3-0B9E-4B4F-83DE-0A5D6E46877F @default.
- Q91313998 P2093 Q91313998-926B8237-2483-44EF-8EF1-2F49BCFCD358 @default.
- Q91313998 P2093 Q91313998-950758CF-B2CD-430C-887C-50A77D611074 @default.
- Q91313998 P304 Q91313998-C7F1E118-9F8D-43EF-A421-4522B4D5E318 @default.
- Q91313998 P31 Q91313998-DBEE36D0-8507-4F2B-BFC4-583179BFCE23 @default.
- Q91313998 P356 Q91313998-C60E3F02-F61C-419C-AF3D-D5924902B44F @default.
- Q91313998 P433 Q91313998-90A45527-1F3D-483D-BFB8-E720426587BB @default.
- Q91313998 P478 Q91313998-8A664B0A-B660-4578-944E-483F5E1A80E6 @default.
- Q91313998 P50 Q91313998-BBE187E6-C99D-4060-90B7-7E0B68F06F90 @default.
- Q91313998 P577 Q91313998-37B1AE51-A403-470D-BD5F-B96667C7447E @default.
- Q91313998 P698 Q91313998-1CCE0876-1986-4AC1-9016-86254E4F156D @default.
- Q91313998 P921 Q91313998-517AD579-AE1C-4E48-A4E9-FB1B0068220D @default.
- Q91313998 P921 Q91313998-68F41700-6E10-4F64-B8A4-85FDA788484F @default.
- Q91313998 P921 Q91313998-92EF054F-1DF6-41B0-804D-2761FE39CD0D @default.
- Q91313998 P356 13696998.2018.1521416 @default.
- Q91313998 P698 30188231 @default.
- Q91313998 P1433 Q6295521 @default.
- Q91313998 P1476 "Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US" @default.
- Q91313998 P2093 "Josephine L Feliciano" @default.
- Q91313998 P2093 "Kristel Vandormael" @default.
- Q91313998 P2093 "Ralph P Insinga" @default.
- Q91313998 P2093 "Sory Traore" @default.
- Q91313998 P2093 "Thomas Burke" @default.
- Q91313998 P304 "1191-1205" @default.
- Q91313998 P31 Q13442814 @default.
- Q91313998 P356 "10.1080/13696998.2018.1521416" @default.
- Q91313998 P433 "12" @default.
- Q91313998 P478 "21" @default.
- Q91313998 P50 Q60169362 @default.
- Q91313998 P577 "2018-09-21T00:00:00Z" @default.
- Q91313998 P698 "30188231" @default.
- Q91313998 P921 Q13896859 @default.
- Q91313998 P921 Q30 @default.
- Q91313998 P921 Q3658562 @default.